Dianthus Therapeutics Inc. (DNTH) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-25
9:00 pm
Sale
2025-11-2113DDianthus Therapeutics, Inc.
DNTH
Fairmount Funds Management LLC2,139,635
4.900%
-1,912,417decrease
(-47.20%)
Filing
History
2025-11-19
9:15 pm
Sale
2025-11-1713DDianthus Therapeutics, Inc.
DNTH
Avidity Partners Management LP2,104,184
4.900%
-1,274,755decrease
(-37.73%)
Filing
History
2025-11-14
4:46 pm
Purchase
2025-09-3013GDianthus Therapeutics, Inc.
DNTH
Octagon Capital Advisors LP2,416,667
6.100%
306,500increase
(+14.52%)
Filing
History
2025-11-14
4:30 pm
Sale
2025-09-3013GDianthus Therapeutics, Inc.
DNTH
BCLS Fund III Investments, LP1,315,892
3.100%
-1,166,358decrease
(-46.99%)
Filing
History
2025-11-14
4:13 pm
Purchase
2025-09-3013GDianthus Therapeutics, Inc.
DNTH
RA CAPITAL MANAGEMENT L.P.3,866,733
9.500%
1,000,000increase
(+34.88%)
Filing
History
2025-11-14
4:06 pm
Sale
2025-09-3013GDianthus Therapeutics, Inc.
DNTH
Vestal Point Capital, LP1,180,000
3.000%
-2,020,000decrease
(-63.13%)
Filing
History
2025-11-14
08:09 am
Sale
2025-09-3013GDianthus Therapeutics, Inc.
DNTH
Deep Track Capital, LP0
0.000%
-2,357,702decrease
(Position Closed)
Filing
History
2025-11-12
09:33 am
Purchase
2025-09-3013GDianthus Therapeutics, Inc.
DNTH
WELLINGTON MANAGEMENT GROUP LLP2,577,662
6.500%
2,577,662increase
(New Position)
Filing
History
2025-11-05
11:30 am
Purchase
2025-09-3013GDianthus Therapeutics, Inc.
DNTH
FMR LLC5,970,638
15.000%
1,488,029increase
(+33.20%)
Filing
History
2025-09-15
4:15 pm
Purchase
2025-09-1113DDianthus Therapeutics, Inc.
DNTH
Fairmount Funds Management LLC4,052,052
9.900%
1,094,667increase
(+37.01%)
Filing
History
2025-09-12
4:10 pm
Purchase
2025-09-1113GDianthus Therapeutics, Inc.
DNTH
Point72 Asset Management, L.P.2,121,140
5.300%
675,315increase
(+46.71%)
Filing
History
2025-08-14
5:58 pm
Sale
2025-06-3013GDianthus Therapeutics, Inc.
DNTH
Venrock Healthcare Capital Partners III, L.P.1,000,000
3.100%
-744,373decrease
(-42.67%)
Filing
History
2025-08-14
5:33 pm
Sale
2025-06-3013GDianthus Therapeutics, Inc.
DNTH
Point72 Asset Management, L.P.1,445,825
4.500%
-448,479decrease
(-23.68%)
Filing
History
2025-08-14
4:00 pm
Sale
2025-06-3013GDianthus Therapeutics, Inc.
DNTH
BCLS Fund III Investments, LP2,482,250
7.500%
-207,457decrease
(-7.71%)
Filing
History
2025-08-14
3:47 pm
Purchase
2025-06-3013GDianthus Therapeutics, Inc.
DNTH
Vestal Point Capital, LP3,200,000
9.950%
1,499,931increase
(+88.23%)
Filing
History
2025-05-15
4:55 pm
Unchanged
2025-03-3113GDianthus Therapeutics, Inc.
DNTH
RA CAPITAL MANAGEMENT L.P.2,866,733
8.900%
0
(Unchanged)
Filing
History
2025-05-15
4:34 pm
Unchanged
2025-03-3113GDianthus Therapeutics, Inc.
DNTH
TCG Crossover GP II, LLC1,501,624
4.700%
0
(Unchanged)
Filing
History
2025-05-15
4:14 pm
Purchase
2025-03-3113GDianthus Therapeutics, Inc.
DNTH
Vestal Point Capital, LP1,700,069
5.300%
1,700,069increase
(New Position)
Filing
History
2025-05-12
10:28 am
Purchase
2025-03-3113GDianthus Therapeutics, Inc.
DNTH
FMR LLC4,482,609
14.000%
2,264,397increase
(+102.08%)
Filing
History
2025-04-24
2:17 pm
Sale
2025-03-3113GDianthus Therapeutics, Inc.
DNTH
BlackRock Inc.
BLK
1,600,153
5.000%
-44,666decrease
(-2.72%)
Filing
History
Goto 0, 1, 2, 3, Next